Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. (Q53576275)
Jump to navigation
Jump to search
scientific article published in January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. |
scientific article published in January 2007 |
Statements
Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. (English)
1 reference
Jianming Duan
1 reference
Jay Friedman
1 reference
Liesl Nottingham
1 reference
Zhong Chen
1 reference
Gulshan Ara
1 reference
Carter Van Waes
1 reference
1 January 2007
1 reference
6
1 reference
1
1 reference
37-50
1 reference
Identifiers
1 reference